MACROPHAGE FATTY ACID METABOLISM IN IMMUNITY TO HELMINTHS
蠕虫免疫中的巨噬细胞脂肪酸代谢
基本信息
- 批准号:8887045
- 负责人:
- 金额:$ 38.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-01-13 至 2015-10-31
- 项目状态:已结题
- 来源:
- 关键词:AcetatesAcid LipaseAddressAdipose tissueAdoptedAgonistAttentionCD36 geneCell RespirationCellsChemicalsChronicCitratesCitric Acid CycleCytosolDeveloping CountriesDietDiseaseDistalEnzymesExhibitsFaceFatty AcidsFatty acid glycerol estersGene ExpressionGenesGeneticGlucoseGlutamineGrantHealthHelminthsHepatocyteHistone AcetylationHomeostasisHost DefenseImmune responseImmunityInfectionInflammationInflammatoryInjection of therapeutic agentInterferonsInterleukin-13Interleukin-4LigandsLipolysisLiverMacrophage ActivationMediatingMediator of activation proteinMetabolicMetabolic ControlMetabolic DiseasesMetabolismMitochondriaMorbidity - disease rateNematodaNematospiroides dubiusNutrientObesityOrganOrganismOutcomeOxidative PhosphorylationOxygen ConsumptionParasitesPlatyhelminthsPlayProcessProductionPublicationsReportingResearchResistance to infectionRestRoleSTAT6 Transcription FactorSchistosoma mansoniSiteSocietiesSourceSystemT-Cell ProliferationTimeTissuesTriglyceridesWound Healingadaptive immunityaerobic glycolysisbaseburden of illnesscell typecytokinefatty acid metabolismfatty acid oxidationinhibitor/antagonistlipid metabolismloss of functionmacrophagemicrobialneglected tropical diseasesoxidationpathogenpreferenceprogramsreceptorrespiratoryresponsetissue repairtranscription factoruptake
项目摘要
DESCRIPTION (provided by applicant): Helminth parasites are endemic in many developing countries. The overall burden of disease due to these pathogens is high, with approximately 300 million infected people suffering from severe morbidity. Here we will focus on M2 macrophages, which play crucial host protective roles in helminth infections. Macrophages can adopt different activation states depending on context. Interferon-γ in combination with TLR agonists promotes M1 (or classical) activation, whereas the cytokines IL-4 and IL-13 promote M2 (or alternative) activation. Differential functions in M1 and M2 macrophages are supported by distinct core metabolisms, with M1 cells committing to aerobic glycolysis, and M2 macrophages utilizing fatty acid oxidation (FAO) and mitochondrial oxidative phosphorylation. Indeed, FAO has been shown to be necessary for M2 activation. This realization has focused our attention on fatty acid metabolism, which since it is essential for M2 activation must, by definition, be an essential face of protection against helminth infections. Fatty acids for FAO are derived from the lysosomal lipolysis of triacylglycerols, which are sourced either from the exterior or through endogenous synthesis of fatty acids. Despite the fact that it is clear that FAO is essential for M2 activation the underlying reasons for the importance of this type of metabolism for M2 activation are unclear. We hypothesize that FAO serves as an efficient source of citrate for export into the cytosol where it can be used for processes that are critical for M2 activation such as synthesis of fatty acids for FAO and to act as ligands for PPARs, and the production of acetate for the acetylation of histones to permit the expression of M2 genes. In addition to their role in immunity
to helminths, M2 macrophages play roles in wound healing, and in whole body metabolic homeostasis. Remarkably, helminth infection has been reported to be capable of mitigating the metabolic consequences of a high fat diet. We hypothesize that strong type 2 immunity induced by helminth infection is able to maintain metabolic homeostasis by broadly supporting M2 activation in tissues distal to the site of infection and will explore this in our third aim. The specific aims of this project are: 1. To establish whether fatty acid synthesis is necessary for M2 activation. 2. To assess the metabolic control of histone acetylation in M2 activation. 3. To determine whether type 2 immunity in helminth infection modulates metabolic homeostasis by broadly supporting M2 activation. We will use genetic loss of function and chemical inhibitor approaches to target key genes encoding enzymes, transcription factors and receptors involved in lipid metabolism to explore M2 activation in reductionist systems and during infection with helminth parasites. We will examine the outcome of alterations in lipid metabolism on infection with these organisms, and will examine the underlying basis for beneficial effects of helminth infections on metabolic disorders associated with obesity.
描述(由申请人提供):蠕虫寄生虫在许多发展中国家流行。这些病原体造成的总体疾病负担很高,约有3亿感染者严重发病。在这里,我们将重点关注M2巨噬细胞,它在蠕虫感染中起着至关重要的宿主保护作用。宏程序可以根据上下文采用不同的激活状态。干扰素-γ与TLR激动剂组合促进M1(或经典)活化,而细胞因子IL-4和IL-13促进M2(或替代)活化。M1和M2巨噬细胞的不同功能由不同的核心代谢支持,M1细胞致力于有氧糖酵解,M2巨噬细胞利用脂肪酸氧化(FAO)和线粒体氧化磷酸化。事实上,FAO已被证明是M2激活所必需的。这一认识使我们的注意力集中在脂肪酸代谢上,因为它对M2活化至关重要,根据定义,它必须是保护免受蠕虫感染的重要因素。FAO的脂肪酸来源于三酰甘油的溶酶体脂解,三酰甘油来源于外部或通过内源性脂肪酸合成。尽管FAO对M2活化至关重要,但这种代谢对M2活化的重要性的根本原因尚不清楚。我们假设FAO作为柠檬酸盐的有效来源,可输出到胞质溶胶中,在胞质溶胶中可用于对M2活化至关重要的过程,如FAO的脂肪酸合成,并作为PPARs的配体,以及用于组蛋白乙酰化以允许M2基因表达的乙酸盐的产生。除了在免疫方面的作用外,
对于蠕虫,M2巨噬细胞在伤口愈合和全身代谢稳态中起作用。值得注意的是,据报道蠕虫感染能够减轻高脂肪饮食的代谢后果。我们假设,蠕虫感染诱导的2型强免疫能够通过广泛支持感染部位远端组织中的M2激活来维持代谢稳态,并将在我们的第三个目标中对此进行探索。该项目的具体目标是:1。确定脂肪酸合成是否是M2激活所必需的。2.评估M2活化中组蛋白乙酰化的代谢控制。3.确定蠕虫感染中的2型免疫是否通过广泛支持M2激活来调节代谢稳态。我们将使用遗传功能丧失和化学抑制剂的方法来靶向关键基因编码酶,转录因子和受体参与脂质代谢,探索M2激活还原系统和蠕虫寄生虫感染期间。我们将研究这些生物体感染后脂质代谢改变的结果,并将研究蠕虫感染对肥胖相关代谢紊乱有益影响的潜在基础。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
EDWARD J. PEARCE其他文献
Schistosomiasis vaccine
血吸虫病疫苗
- DOI:
10.1038/334478b0 - 发表时间:
1988-08-01 - 期刊:
- 影响因子:48.500
- 作者:
ALAN SHER;EDWARD J. PEARCE - 通讯作者:
EDWARD J. PEARCE
EDWARD J. PEARCE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('EDWARD J. PEARCE', 18)}}的其他基金
MANIPULATING DENDRITIC CELL METABOLISM TO PROMOTE CANCER IMMUNITY
操纵树突状细胞代谢以促进癌症免疫
- 批准号:
9133018 - 财政年份:2016
- 资助金额:
$ 38.13万 - 项目类别:
MANIPULATING DENDRITIC CELL METABOLISM TO PROMOTE CANCER IMMUNITY
操纵树突状细胞代谢以促进癌症免疫
- 批准号:
9067234 - 财政年份:2016
- 资助金额:
$ 38.13万 - 项目类别:
MACROPHAGE FATTY ACID METABOLISM IN IMMUNITY TO HELMINTHS
蠕虫免疫中的巨噬细胞脂肪酸代谢
- 批准号:
9187865 - 财政年份:2015
- 资助金额:
$ 38.13万 - 项目类别:
MANIPULATING DENDRITIC CELL METABOLISM TO PROMOTE CANCER IMMUNITY
操纵树突状细胞代谢以促进癌症免疫
- 批准号:
8370766 - 财政年份:2012
- 资助金额:
$ 38.13万 - 项目类别:
MANIPULATING DENDRITIC CELL METABOLISM TO PROMOTE CANCER IMMUNITY
操纵树突状细胞代谢以促进癌症免疫
- 批准号:
8843386 - 财政年份:2012
- 资助金额:
$ 38.13万 - 项目类别:
MANIPULATING DENDRITIC CELL METABOLISM TO PROMOTE CANCER IMMUNITY
操纵树突状细胞代谢以促进癌症免疫
- 批准号:
8677812 - 财政年份:2012
- 资助金额:
$ 38.13万 - 项目类别:
MANIPULATING DENDRITIC CELL METABOLISM TO PROMOTE CANCER IMMUNITY
操纵树突状细胞代谢以促进癌症免疫
- 批准号:
8519388 - 财政年份:2012
- 资助金额:
$ 38.13万 - 项目类别:
相似海外基金
Long-lasting recovery of lysosomal acid lipase deficiency using non-viral delivery of non-integrating episomal DNA constructs.
使用非整合附加型 DNA 构建体的非病毒递送来长期恢复溶酶体酸性脂肪酶缺乏症。
- 批准号:
478865 - 财政年份:2023
- 资助金额:
$ 38.13万 - 项目类别:
Operating Grants
Smooth Muscle Cell Lysosomal Acid Lipase in Atherosclerosis
动脉粥样硬化中的平滑肌细胞溶酶体酸性脂肪酶
- 批准号:
415905 - 财政年份:2019
- 资助金额:
$ 38.13万 - 项目类别:
Studentship Programs
The Role of Lysosomal Acid Lipase in Atherosclerotic Lesion Smooth Muscle Cells
溶酶体酸性脂肪酶在动脉粥样硬化病变平滑肌细胞中的作用
- 批准号:
406411 - 财政年份:2018
- 资助金额:
$ 38.13万 - 项目类别:
Studentship Programs
Roles of Lysosomal Acid Lipase in Development of Coronary Artery Disease
溶酶体酸性脂肪酶在冠状动脉疾病发展中的作用
- 批准号:
17K09859 - 财政年份:2017
- 资助金额:
$ 38.13万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Relative deficiency of lysosomal acid lipase in arterial smooth muscle cells as a novel target for atherosclerosis treatment and prevention
动脉平滑肌细胞中溶酶体酸性脂肪酶的相对缺乏作为动脉粥样硬化治疗和预防的新靶点
- 批准号:
372472 - 财政年份:2017
- 资助金额:
$ 38.13万 - 项目类别:
Operating Grants
Characterization of a Lysosomal Acid Lipase Variant Associated with Coronary Disease
与冠心病相关的溶酶体酸性脂肪酶变体的表征
- 批准号:
9121663 - 财政年份:2016
- 资助金额:
$ 38.13万 - 项目类别:
Characterization of a Lysosomal Acid Lipase Variant Associated with Coronary Disease
与冠心病相关的溶酶体酸性脂肪酶变体的表征
- 批准号:
9269076 - 财政年份:2016
- 资助金额:
$ 38.13万 - 项目类别:
Novel Dried Blood Spot Mass Spectrometry Functional Assays for Lysosomal Acid Lipase and N-acetylgalactosamine-sulfate Sulfatases for Use in Newborn Screening
用于新生儿筛查的溶酶体酸性脂肪酶和 N-乙酰半乳糖胺硫酸酯硫酸酯酶的新型干血斑质谱功能分析
- 批准号:
9238498 - 财政年份:2015
- 资助金额:
$ 38.13万 - 项目类别:
Role of lysosomal acid lipase in regulating insulin secretion
溶酶体酸性脂肪酶在调节胰岛素分泌中的作用
- 批准号:
nhmrc : 1051658 - 财政年份:2013
- 资助金额:
$ 38.13万 - 项目类别:
Project Grants
The role of lysosomal acid lipase in the regulation of the ATP-binding cassette transporter A1 and reverse cholesterol transport
溶酶体酸性脂肪酶在 ATP 结合盒转运蛋白 A1 和反向胆固醇转运调节中的作用
- 批准号:
253483 - 财政年份:2012
- 资助金额:
$ 38.13万 - 项目类别: